ABSTRACT. In this Part II review, as a complement to the Part I published in this supplement, the authors cover the imaging techniques that evaluates the Alzheimer's disease according to the different metabolic and molecular profiles. In this section MR spectroscopy, FDG-PET and amyloid PET are deeply discussed.</div
'Alzheimer's disease is the most common cause of dementia and its prevalence is expected to increase...
The rapid progress in advanced imaging technologies has expanded our toolbox for monitoring a variet...
Today, a number of complementary molecular imaging methods are at our disposal, which can make a rel...
ABSTRACT. In this Part II review, as a complement to the Part I published in this supplement, the au...
Alzheimer's disease is the most common form of dementia and is a significant burden for affected pat...
Alzheimer’s disease is the most common form of dementia and is a significant burden for affect...
Alzheimer's disease (AD), a progressive neurodegenerative disorder, is the most common cause of deme...
Multiple factors, namely amyloid, tau, inflammation, metabolic, and perfusion changes, contribute to...
PET based tools can improve the early diagnosis of Alzheimer's disease (AD) and differential diagnos...
Alzheimer's disease (AD) is the most common form of dementia; a progressive neurodegenerative diseas...
PET based tools can improve the early diagnosis of Alzheimer’s disease (AD) and differential diagnos...
ABSTRACT The authors make a complete review of the potential clinical applications of traditional an...
Current Positron Emission Tomography (PET) biomarkers for Alzheimer’s disease (AD) assess either neu...
Positron Emission Tomography (PET) is a noninvasive imaging technique and it allows the visualizatio...
Although recent developments in imaging biomarkers have revolutionized the diagnosis of Alzheimer's ...
'Alzheimer's disease is the most common cause of dementia and its prevalence is expected to increase...
The rapid progress in advanced imaging technologies has expanded our toolbox for monitoring a variet...
Today, a number of complementary molecular imaging methods are at our disposal, which can make a rel...
ABSTRACT. In this Part II review, as a complement to the Part I published in this supplement, the au...
Alzheimer's disease is the most common form of dementia and is a significant burden for affected pat...
Alzheimer’s disease is the most common form of dementia and is a significant burden for affect...
Alzheimer's disease (AD), a progressive neurodegenerative disorder, is the most common cause of deme...
Multiple factors, namely amyloid, tau, inflammation, metabolic, and perfusion changes, contribute to...
PET based tools can improve the early diagnosis of Alzheimer's disease (AD) and differential diagnos...
Alzheimer's disease (AD) is the most common form of dementia; a progressive neurodegenerative diseas...
PET based tools can improve the early diagnosis of Alzheimer’s disease (AD) and differential diagnos...
ABSTRACT The authors make a complete review of the potential clinical applications of traditional an...
Current Positron Emission Tomography (PET) biomarkers for Alzheimer’s disease (AD) assess either neu...
Positron Emission Tomography (PET) is a noninvasive imaging technique and it allows the visualizatio...
Although recent developments in imaging biomarkers have revolutionized the diagnosis of Alzheimer's ...
'Alzheimer's disease is the most common cause of dementia and its prevalence is expected to increase...
The rapid progress in advanced imaging technologies has expanded our toolbox for monitoring a variet...
Today, a number of complementary molecular imaging methods are at our disposal, which can make a rel...